Edmonton – September 17, 2026 -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has dismissed Curaleaf Holdings' regulatory application to halt its at-the-market (ATM) share program, calling the move a distraction from an undervalued hostile takeover bid.

Cancún, Mexico – September 17, 2026 -- Sunset World Group will launch a formal partnership with recycling non-profit ECOCE on September 15, 2026, to align its hotel operations with Mexico's Circular Economy Law.

Greenville, S.C. – September 17, 2026 -- Senior Helpers Greenville has become the first private duty in-home care provider in the United States to earn Age-Friendly Care at Home certification from the Community Health Accreditation Partners (CHAP), the locally owned franchise confirmed August 27, 2026.

San Ramon, Calif. – September 17, 2026 -- SnippetSentry has entered a partnership with Knox Systems to pursue Federal Risk and Authorization Management Program (FedRAMP) Moderate Authorization, targeting federal agencies that need compliant capture of mobile messaging communications.

Arlington, Va. – September 17, 2026 -- The International Safety Equipment Association (ISEA) has released ANSI/ISEA Z89.1-2026, the updated American National Standard for Industrial Head Protection, approved by the American National Standards Institute.

United States – September 17, 2026 -- Nearly 27% of taxi and rideshare vehicles across 16 major U.S. cities are operating with at least one open, unfixed safety recall, according to a CARFAX analysis of almost 438,000 vehicle identification numbers (VINs).

Los Angeles – September 17, 2026 -- The U.S. Food and Drug Administration has granted Breakthrough Therapy designation to Armata Pharmaceuticals' AP-SA02, an intravenous multi-phage candidate for complicated Staphylococcus aureus bacteremia, stacking the designation atop existing Fast Track and Qualified Infectious Disease Product status.

Aubonne – September 16, 2026 -- Intuitive has secured CE mark approval for its da Vinci SP surgical system to perform transvaginal gynecologic procedures, marking the first such indication for the Single Port platform anywhere in the world.

Suzhou – – September 16, 2026 -- Accro Bioscience said AC-101 tablets have been included in the National Medical Products Administration's Center for Drug Evaluation (CDE) "Caring Plan-Extension" pilot program, targeting Blau syndrome as the proposed indication, with the public notice period closing September 11, 2026.

Boston – September 16, 2026 -- PerZeption Inc. has secured a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute to fund development of a new photostress recovery test for age-related macular degeneration (AMD), a condition affecting an estimated 20 million people in the United States.